カテゴリー： 世界, 部品/材料, LP Information

世界の抗結核剤-9市場予測 2023年-2029年

【英語タイトル】Global Antituberculosis Agent-9 Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC03062）・商品コード：LP23DC03062
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：103
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の抗結核剤-9市場」は、過去の販売実績から2022年の世界の抗結核剤-9の総販売量を検討し、2023年から2029年の予測される抗結核剤-9の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の抗結核剤-9の市場規模を掲載し、XXX百万米ドル規模の世界の抗結核剤-9市場の詳細な分析を提供します。本インサイトレポートは、世界の抗結核剤-9業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の抗結核剤-9市場における各社の独自のポジションをより深く理解するために、抗結核剤-9製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の抗結核剤-9市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。抗結核剤-9の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。抗結核剤-9の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。抗結核剤-9のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

抗結核剤-9の世界主要メーカーとしては、MedChemExpress、 Pfizer Inc.、 Sanofi S.A.、 Novartis International AG、 GlaxoSmithKline plc、 Johnson & Johnson、 Lupin Limited、 Otsuka Pharmaceutical Co., Ltd.、 Eli Lilly and Company、 Sandoz International GmbH、 Mylan N.V.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の抗結核剤-9市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では抗結核剤-9市場をセグメンテーションし、種類別 (固体、液体)、用途別 (経口剤、注射剤)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：固体、液体

・用途別区分：経口剤、注射剤

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の抗結核剤-9市場の10年間の市場状況・展望は？
・世界および地域別に見た抗結核剤-9市場成長の要因は何か？
・抗結核剤-9の市場機会はエンドマーケットの規模によってどのように変化するのか？
・抗結核剤-9のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：抗結核剤-9の年間販売量2018-2029、地域別現状・将来分析
・抗結核剤-9の種類別セグメント：固体、液体
・抗結核剤-9の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・抗結核剤-9の用途別セグメント：経口剤、注射剤
・抗結核剤-9の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の抗結核剤-9市場
・企業別のグローバル抗結核剤-9市場データ：2018-2023年の年間販売量、市場シェア
・企業別の抗結核剤-9の年間売上：2018-2023年の売上、市場シェア
・企業別の抗結核剤-9販売価格
・主要企業の抗結核剤-9生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

抗結核剤-9の地域別レビュー
・地域別の抗結核剤-9市場規模2018-2023：年間販売量、売上
・主要国別の抗結核剤-9市場規模2018-2023：年間販売量、売上
・南北アメリカの抗結核剤-9販売の成長
・アジア太平洋の抗結核剤-9販売の成長
・ヨーロッパの抗結核剤-9販売の成長
・中東・アフリカの抗結核剤-9販売の成長

南北アメリカ市場
・南北アメリカの国別の抗結核剤-9販売量、売上（2018-2023）
・南北アメリカの抗結核剤-9の種類別販売量
・南北アメリカの抗結核剤-9の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の抗結核剤-9販売量、売上（2018-2023）
・アジア太平洋の抗結核剤-9の種類別販売量
・アジア太平洋の抗結核剤-9の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の抗結核剤-9販売量、売上（2018-2023）
・ヨーロッパの抗結核剤-9の種類別販売量
・ヨーロッパの抗結核剤-9の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の抗結核剤-9販売量、売上（2018-2023）
・中東・アフリカの抗結核剤-9の種類別販売量
・中東・アフリカの抗結核剤-9の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・抗結核剤-9の製造コスト構造分析
・抗結核剤-9の製造プロセス分析
・抗結核剤-9の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・抗結核剤-9の主要なグローバル販売業者
・抗結核剤-9の主要なグローバル顧客

地域別の抗結核剤-9市場予測レビュー
・地域別の抗結核剤-9市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・抗結核剤-9の種類別市場規模予測
・抗結核剤-9の用途別市場規模予測

主要企業分析
MedChemExpress、 Pfizer Inc.、 Sanofi S.A.、 Novartis International AG、 GlaxoSmithKline plc、 Johnson & Johnson、 Lupin Limited、 Otsuka Pharmaceutical Co., Ltd.、 Eli Lilly and Company、 Sandoz International GmbH、 Mylan N.V.
・企業情報
・抗結核剤-9製品
・抗結核剤-9販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Antituberculosis Agent-9 market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antituberculosis Agent-9 players cover MedChemExpress, Pfizer Inc., Sanofi S.A., Novartis International AG, GlaxoSmithKline plc, Johnson & Johnson, Lupin Limited, Otsuka Pharmaceutical Co., Ltd. and Eli Lilly and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Antituberculosis Agent-9 Industry Forecast” looks at past sales and reviews total world Antituberculosis Agent-9 sales in 2022, providing a comprehensive analysis by region and market sector of projected Antituberculosis Agent-9 sales for 2023 through 2029. With Antituberculosis Agent-9 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antituberculosis Agent-9 industry.
This Insight Report provides a comprehensive analysis of the global Antituberculosis Agent-9 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antituberculosis Agent-9 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antituberculosis Agent-9 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antituberculosis Agent-9 and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antituberculosis Agent-9.
This report presents a comprehensive overview, market shares, and growth opportunities of Antituberculosis Agent-9 market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Solid State
Liquid State
Segmentation by application
Oral
Injection
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
MedChemExpress
Pfizer Inc.
Sanofi S.A.
Novartis International AG
GlaxoSmithKline plc
Johnson & Johnson
Lupin Limited
Otsuka Pharmaceutical Co., Ltd.
Eli Lilly and Company
Sandoz International GmbH
Mylan N.V.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antituberculosis Agent-9 market?
What factors are driving Antituberculosis Agent-9 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antituberculosis Agent-9 market opportunities vary by end market size?
How does Antituberculosis Agent-9 break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antituberculosis Agent-9 Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antituberculosis Agent-9 by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antituberculosis Agent-9 by Country/Region, 2018, 2022 & 2029
2.2 Antituberculosis Agent-9 Segment by Type
2.2.1 Solid State
2.2.2 Liquid State
2.3 Antituberculosis Agent-9 Sales by Type
2.3.1 Global Antituberculosis Agent-9 Sales Market Share by Type (2018-2023)
2.3.2 Global Antituberculosis Agent-9 Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antituberculosis Agent-9 Sale Price by Type (2018-2023)
2.4 Antituberculosis Agent-9 Segment by Application
2.4.1 Oral
2.4.2 Injection
2.5 Antituberculosis Agent-9 Sales by Application
2.5.1 Global Antituberculosis Agent-9 Sale Market Share by Application (2018-2023)
2.5.2 Global Antituberculosis Agent-9 Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antituberculosis Agent-9 Sale Price by Application (2018-2023)
3 Global Antituberculosis Agent-9 by Company
3.1 Global Antituberculosis Agent-9 Breakdown Data by Company
3.1.1 Global Antituberculosis Agent-9 Annual Sales by Company (2018-2023)
3.1.2 Global Antituberculosis Agent-9 Sales Market Share by Company (2018-2023)
3.2 Global Antituberculosis Agent-9 Annual Revenue by Company (2018-2023)
3.2.1 Global Antituberculosis Agent-9 Revenue by Company (2018-2023)
3.2.2 Global Antituberculosis Agent-9 Revenue Market Share by Company (2018-2023)
3.3 Global Antituberculosis Agent-9 Sale Price by Company
3.4 Key Manufacturers Antituberculosis Agent-9 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antituberculosis Agent-9 Product Location Distribution
3.4.2 Players Antituberculosis Agent-9 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antituberculosis Agent-9 by Geographic Region
4.1 World Historic Antituberculosis Agent-9 Market Size by Geographic Region (2018-2023)
4.1.1 Global Antituberculosis Agent-9 Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antituberculosis Agent-9 Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antituberculosis Agent-9 Market Size by Country/Region (2018-2023)
4.2.1 Global Antituberculosis Agent-9 Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antituberculosis Agent-9 Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antituberculosis Agent-9 Sales Growth
4.4 APAC Antituberculosis Agent-9 Sales Growth
4.5 Europe Antituberculosis Agent-9 Sales Growth
4.6 Middle East & Africa Antituberculosis Agent-9 Sales Growth
5 Americas
5.1 Americas Antituberculosis Agent-9 Sales by Country
5.1.1 Americas Antituberculosis Agent-9 Sales by Country (2018-2023)
5.1.2 Americas Antituberculosis Agent-9 Revenue by Country (2018-2023)
5.2 Americas Antituberculosis Agent-9 Sales by Type
5.3 Americas Antituberculosis Agent-9 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antituberculosis Agent-9 Sales by Region
6.1.1 APAC Antituberculosis Agent-9 Sales by Region (2018-2023)
6.1.2 APAC Antituberculosis Agent-9 Revenue by Region (2018-2023)
6.2 APAC Antituberculosis Agent-9 Sales by Type
6.3 APAC Antituberculosis Agent-9 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antituberculosis Agent-9 by Country
7.1.1 Europe Antituberculosis Agent-9 Sales by Country (2018-2023)
7.1.2 Europe Antituberculosis Agent-9 Revenue by Country (2018-2023)
7.2 Europe Antituberculosis Agent-9 Sales by Type
7.3 Europe Antituberculosis Agent-9 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antituberculosis Agent-9 by Country
8.1.1 Middle East & Africa Antituberculosis Agent-9 Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antituberculosis Agent-9 Revenue by Country (2018-2023)
8.2 Middle East & Africa Antituberculosis Agent-9 Sales by Type
8.3 Middle East & Africa Antituberculosis Agent-9 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antituberculosis Agent-9
10.3 Manufacturing Process Analysis of Antituberculosis Agent-9
10.4 Industry Chain Structure of Antituberculosis Agent-9
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antituberculosis Agent-9 Distributors
11.3 Antituberculosis Agent-9 Customer
12 World Forecast Review for Antituberculosis Agent-9 by Geographic Region
12.1 Global Antituberculosis Agent-9 Market Size Forecast by Region
12.1.1 Global Antituberculosis Agent-9 Forecast by Region (2024-2029)
12.1.2 Global Antituberculosis Agent-9 Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antituberculosis Agent-9 Forecast by Type
12.7 Global Antituberculosis Agent-9 Forecast by Application
13 Key Players Analysis
13.1 MedChemExpress
13.1.1 MedChemExpress Company Information
13.1.2 MedChemExpress Antituberculosis Agent-9 Product Portfolios and Specifications
13.1.3 MedChemExpress Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 MedChemExpress Main Business Overview
13.1.5 MedChemExpress Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Antituberculosis Agent-9 Product Portfolios and Specifications
13.2.3 Pfizer Inc. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Sanofi S.A.
13.3.1 Sanofi S.A. Company Information
13.3.2 Sanofi S.A. Antituberculosis Agent-9 Product Portfolios and Specifications
13.3.3 Sanofi S.A. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sanofi S.A. Main Business Overview
13.3.5 Sanofi S.A. Latest Developments
13.4 Novartis International AG
13.4.1 Novartis International AG Company Information
13.4.2 Novartis International AG Antituberculosis Agent-9 Product Portfolios and Specifications
13.4.3 Novartis International AG Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Novartis International AG Main Business Overview
13.4.5 Novartis International AG Latest Developments
13.5 GlaxoSmithKline plc
13.5.1 GlaxoSmithKline plc Company Information
13.5.2 GlaxoSmithKline plc Antituberculosis Agent-9 Product Portfolios and Specifications
13.5.3 GlaxoSmithKline plc Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GlaxoSmithKline plc Main Business Overview
13.5.5 GlaxoSmithKline plc Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Antituberculosis Agent-9 Product Portfolios and Specifications
13.6.3 Johnson & Johnson Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Lupin Limited
13.7.1 Lupin Limited Company Information
13.7.2 Lupin Limited Antituberculosis Agent-9 Product Portfolios and Specifications
13.7.3 Lupin Limited Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Lupin Limited Main Business Overview
13.7.5 Lupin Limited Latest Developments
13.8 Otsuka Pharmaceutical Co., Ltd.
13.8.1 Otsuka Pharmaceutical Co., Ltd. Company Information
13.8.2 Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Product Portfolios and Specifications
13.8.3 Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Otsuka Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Otsuka Pharmaceutical Co., Ltd. Latest Developments
13.9 Eli Lilly and Company
13.9.1 Eli Lilly and Company Company Information
13.9.2 Eli Lilly and Company Antituberculosis Agent-9 Product Portfolios and Specifications
13.9.3 Eli Lilly and Company Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Eli Lilly and Company Main Business Overview
13.9.5 Eli Lilly and Company Latest Developments
13.10 Sandoz International GmbH
13.10.1 Sandoz International GmbH Company Information
13.10.2 Sandoz International GmbH Antituberculosis Agent-9 Product Portfolios and Specifications
13.10.3 Sandoz International GmbH Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sandoz International GmbH Main Business Overview
13.10.5 Sandoz International GmbH Latest Developments
13.11 Mylan N.V.
13.11.1 Mylan N.V. Company Information
13.11.2 Mylan N.V. Antituberculosis Agent-9 Product Portfolios and Specifications
13.11.3 Mylan N.V. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mylan N.V. Main Business Overview
13.11.5 Mylan N.V. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Antituberculosis Agent-9 Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antituberculosis Agent-9 Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Solid State
Table 4. Major Players of Liquid State
Table 5. Global Antituberculosis Agent-9 Sales by Type (2018-2023) & (Tons)
Table 6. Global Antituberculosis Agent-9 Sales Market Share by Type (2018-2023)
Table 7. Global Antituberculosis Agent-9 Revenue by Type (2018-2023) & ($ million)
Table 8. Global Antituberculosis Agent-9 Revenue Market Share by Type (2018-2023)
Table 9. Global Antituberculosis Agent-9 Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Antituberculosis Agent-9 Sales by Application (2018-2023) & (Tons)
Table 11. Global Antituberculosis Agent-9 Sales Market Share by Application (2018-2023)
Table 12. Global Antituberculosis Agent-9 Revenue by Application (2018-2023)
Table 13. Global Antituberculosis Agent-9 Revenue Market Share by Application (2018-2023)
Table 14. Global Antituberculosis Agent-9 Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Antituberculosis Agent-9 Sales by Company (2018-2023) & (Tons)
Table 16. Global Antituberculosis Agent-9 Sales Market Share by Company (2018-2023)
Table 17. Global Antituberculosis Agent-9 Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Antituberculosis Agent-9 Revenue Market Share by Company (2018-2023)
Table 19. Global Antituberculosis Agent-9 Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Antituberculosis Agent-9 Producing Area Distribution and Sales Area
Table 21. Players Antituberculosis Agent-9 Products Offered
Table 22. Antituberculosis Agent-9 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antituberculosis Agent-9 Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Antituberculosis Agent-9 Sales Market Share Geographic Region (2018-2023)
Table 27. Global Antituberculosis Agent-9 Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Antituberculosis Agent-9 Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Antituberculosis Agent-9 Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Antituberculosis Agent-9 Sales Market Share by Country/Region (2018-2023)
Table 31. Global Antituberculosis Agent-9 Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Antituberculosis Agent-9 Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Antituberculosis Agent-9 Sales by Country (2018-2023) & (Tons)
Table 34. Americas Antituberculosis Agent-9 Sales Market Share by Country (2018-2023)
Table 35. Americas Antituberculosis Agent-9 Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Antituberculosis Agent-9 Revenue Market Share by Country (2018-2023)
Table 37. Americas Antituberculosis Agent-9 Sales by Type (2018-2023) & (Tons)
Table 38. Americas Antituberculosis Agent-9 Sales by Application (2018-2023) & (Tons)
Table 39. APAC Antituberculosis Agent-9 Sales by Region (2018-2023) & (Tons)
Table 40. APAC Antituberculosis Agent-9 Sales Market Share by Region (2018-2023)
Table 41. APAC Antituberculosis Agent-9 Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Antituberculosis Agent-9 Revenue Market Share by Region (2018-2023)
Table 43. APAC Antituberculosis Agent-9 Sales by Type (2018-2023) & (Tons)
Table 44. APAC Antituberculosis Agent-9 Sales by Application (2018-2023) & (Tons)
Table 45. Europe Antituberculosis Agent-9 Sales by Country (2018-2023) & (Tons)
Table 46. Europe Antituberculosis Agent-9 Sales Market Share by Country (2018-2023)
Table 47. Europe Antituberculosis Agent-9 Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Antituberculosis Agent-9 Revenue Market Share by Country (2018-2023)
Table 49. Europe Antituberculosis Agent-9 Sales by Type (2018-2023) & (Tons)
Table 50. Europe Antituberculosis Agent-9 Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Antituberculosis Agent-9 Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Antituberculosis Agent-9 Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Antituberculosis Agent-9 Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Antituberculosis Agent-9 Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Antituberculosis Agent-9 Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Antituberculosis Agent-9
Table 58. Key Market Challenges & Risks of Antituberculosis Agent-9
Table 59. Key Industry Trends of Antituberculosis Agent-9
Table 60. Antituberculosis Agent-9 Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Antituberculosis Agent-9 Distributors List
Table 63. Antituberculosis Agent-9 Customer List
Table 64. Global Antituberculosis Agent-9 Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Antituberculosis Agent-9 Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Antituberculosis Agent-9 Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Antituberculosis Agent-9 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Antituberculosis Agent-9 Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Antituberculosis Agent-9 Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Antituberculosis Agent-9 Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Antituberculosis Agent-9 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Antituberculosis Agent-9 Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Antituberculosis Agent-9 Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Antituberculosis Agent-9 Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Antituberculosis Agent-9 Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Antituberculosis Agent-9 Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Antituberculosis Agent-9 Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. MedChemExpress Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 79. MedChemExpress Antituberculosis Agent-9 Product Portfolios and Specifications
Table 80. MedChemExpress Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. MedChemExpress Main Business
Table 82. MedChemExpress Latest Developments
Table 83. Pfizer Inc. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Inc. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 85. Pfizer Inc. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Pfizer Inc. Main Business
Table 87. Pfizer Inc. Latest Developments
Table 88. Sanofi S.A. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi S.A. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 90. Sanofi S.A. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Sanofi S.A. Main Business
Table 92. Sanofi S.A. Latest Developments
Table 93. Novartis International AG Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis International AG Antituberculosis Agent-9 Product Portfolios and Specifications
Table 95. Novartis International AG Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Novartis International AG Main Business
Table 97. Novartis International AG Latest Developments
Table 98. GlaxoSmithKline plc Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 99. GlaxoSmithKline plc Antituberculosis Agent-9 Product Portfolios and Specifications
Table 100. GlaxoSmithKline plc Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. GlaxoSmithKline plc Main Business
Table 102. GlaxoSmithKline plc Latest Developments
Table 103. Johnson & Johnson Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 104. Johnson & Johnson Antituberculosis Agent-9 Product Portfolios and Specifications
Table 105. Johnson & Johnson Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Johnson & Johnson Main Business
Table 107. Johnson & Johnson Latest Developments
Table 108. Lupin Limited Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 109. Lupin Limited Antituberculosis Agent-9 Product Portfolios and Specifications
Table 110. Lupin Limited Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Lupin Limited Main Business
Table 112. Lupin Limited Latest Developments
Table 113. Otsuka Pharmaceutical Co., Ltd. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 114. Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 115. Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Otsuka Pharmaceutical Co., Ltd. Main Business
Table 117. Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 118. Eli Lilly and Company Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 119. Eli Lilly and Company Antituberculosis Agent-9 Product Portfolios and Specifications
Table 120. Eli Lilly and Company Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Eli Lilly and Company Main Business
Table 122. Eli Lilly and Company Latest Developments
Table 123. Sandoz International GmbH Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 124. Sandoz International GmbH Antituberculosis Agent-9 Product Portfolios and Specifications
Table 125. Sandoz International GmbH Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Sandoz International GmbH Main Business
Table 127. Sandoz International GmbH Latest Developments
Table 128. Mylan N.V. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 129. Mylan N.V. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 130. Mylan N.V. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Mylan N.V. Main Business
Table 132. Mylan N.V. Latest Developments
List of Figures
Figure 1. Picture of Antituberculosis Agent-9
Figure 2. Antituberculosis Agent-9 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antituberculosis Agent-9 Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Antituberculosis Agent-9 Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antituberculosis Agent-9 Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Solid State
Figure 10. Product Picture of Liquid State
Figure 11. Global Antituberculosis Agent-9 Sales Market Share by Type in 2022
Figure 12. Global Antituberculosis Agent-9 Revenue Market Share by Type (2018-2023)
Figure 13. Antituberculosis Agent-9 Consumed in Oral
Figure 14. Global Antituberculosis Agent-9 Market: Oral (2018-2023) & (Tons)
Figure 15. Antituberculosis Agent-9 Consumed in Injection
Figure 16. Global Antituberculosis Agent-9 Market: Injection (2018-2023) & (Tons)
Figure 17. Global Antituberculosis Agent-9 Sales Market Share by Application (2022)
Figure 18. Global Antituberculosis Agent-9 Revenue Market Share by Application in 2022
Figure 19. Antituberculosis Agent-9 Sales Market by Company in 2022 (Tons)
Figure 20. Global Antituberculosis Agent-9 Sales Market Share by Company in 2022
Figure 21. Antituberculosis Agent-9 Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Antituberculosis Agent-9 Revenue Market Share by Company in 2022
Figure 23. Global Antituberculosis Agent-9 Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Antituberculosis Agent-9 Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Antituberculosis Agent-9 Sales 2018-2023 (Tons)
Figure 26. Americas Antituberculosis Agent-9 Revenue 2018-2023 ($ Millions)
Figure 27. APAC Antituberculosis Agent-9 Sales 2018-2023 (Tons)
Figure 28. APAC Antituberculosis Agent-9 Revenue 2018-2023 ($ Millions)
Figure 29. Europe Antituberculosis Agent-9 Sales 2018-2023 (Tons)
Figure 30. Europe Antituberculosis Agent-9 Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Antituberculosis Agent-9 Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Antituberculosis Agent-9 Revenue 2018-2023 ($ Millions)
Figure 33. Americas Antituberculosis Agent-9 Sales Market Share by Country in 2022
Figure 34. Americas Antituberculosis Agent-9 Revenue Market Share by Country in 2022
Figure 35. Americas Antituberculosis Agent-9 Sales Market Share by Type (2018-2023)
Figure 36. Americas Antituberculosis Agent-9 Sales Market Share by Application (2018-2023)
Figure 37. United States Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Antituberculosis Agent-9 Sales Market Share by Region in 2022
Figure 42. APAC Antituberculosis Agent-9 Revenue Market Share by Regions in 2022
Figure 43. APAC Antituberculosis Agent-9 Sales Market Share by Type (2018-2023)
Figure 44. APAC Antituberculosis Agent-9 Sales Market Share by Application (2018-2023)
Figure 45. China Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Antituberculosis Agent-9 Sales Market Share by Country in 2022
Figure 53. Europe Antituberculosis Agent-9 Revenue Market Share by Country in 2022
Figure 54. Europe Antituberculosis Agent-9 Sales Market Share by Type (2018-2023)
Figure 55. Europe Antituberculosis Agent-9 Sales Market Share by Application (2018-2023)
Figure 56. Germany Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Antituberculosis Agent-9 Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Application (2018-2023)
Figure 65. Egypt Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Antituberculosis Agent-9 Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Antituberculosis Agent-9 in 2022
Figure 71. Manufacturing Process Analysis of Antituberculosis Agent-9
Figure 72. Industry Chain Structure of Antituberculosis Agent-9
Figure 73. Channels of Distribution
Figure 74. Global Antituberculosis Agent-9 Sales Market Forecast by Region (2024-2029)
Figure 75. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Antituberculosis Agent-9 Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Antituberculosis Agent-9 Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の抗結核剤-9市場予測 2023年-2029年] (コード：LP23DC03062)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗結核剤-9市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のフレッチング防止剤市場予測 2023年-2029年
  • 世界のティーツリーオイル仕上げ剤市場予測 2023年-2029年
  • 世界のシリコーン増粘剤市場予測 2023年-2029年
  • 世界の水系離型剤市場予測 2023年-2029年
  • 世界の農耕地用土壌浄化剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆